INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 12, 2018 |
Director, President & CEO
Trans History: 427
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 129,013 | -- | 129,013 |
| Dec 12, 2018 |
Director, President and CSO
Trans History: 673
|
Director, President and CSO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 129,013 | -- | 129,013 |
| Nov 19, 2012 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 30,800 | $160.59 | 129,200 |
| Jan 05, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 129,902 | -- | 129,902 |
| Jan 02, 2020 |
Director
Trans History: 326
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | $24.41 | 130,095 |
| Jan 19, 2012 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,800 | $20.32 | 130,161 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 24,636 | $20.95 | 130,651 |
| Jan 03, 2011 |
Director
Trans History: 742
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 8,957 | $34.04 | 131,555 |
| Oct 27, 2009 |
Director, CEO and President, Ten Percent Owner
Trans History: 427
|
Director, CEO and President, Ten Percent Owner | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 31,611 | $10.44 | 132,058 |
| Feb 14, 2012 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 7,566 | $111.01 | 132,757 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.